In 2023, Mark Gergen earned $961.80K in total compensation at Poseida Therapeutics, Inc., including $611.67K salary and $336.42K bonus. Most recently sold 2,546,904 shares in Jan 2025. Led Poseida Therapeutics, Inc. as CEO for 1 years.
Compensation History
Annual executive compensation data for Mark Gergen, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$961.80K
Salary
$611.67K
Bonus
$336.42K
Other
$13.71K
Salary
$611.67KBoard Justification
The compensation philosophy aligns with company performance and peer benchmarking, aiming to attract and retain top talent while incentivizing performance.
Bonus
$336.42KBoard Justification
The annual performance-based bonus for 2023 was based on achieving corporate goals set by the Board of Directors, with a target of 55% of annual base salary, resulting in a 100% payout due to meeting performance objectives.
Other Compensation
$13.71KBoard Justification
Other compensation includes 401(k) matching contributions and life insurance premiums.
Restricted Stock
Board Justification
No stock awards vested in 2023 as the focus is on cash compensation and performance bonuses.
Performance Metrics
Performance metrics included corporate goals related to research and development, finance, and business development.
Mark Gergen
Ex-CEO of Poseida Therapeutics, Inc.
Education
MBA from Harvard Business School
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
January 1, 1972 - 53 years ago
CEO of Poseida Therapeutics, Inc. for
1 year 8 months (Feb 2022 - Oct 2023)
Previous Experience
President and Chief Business Officer of Poseida Therapeutics, Inc.
Holdings
Track Mark Gergen's stock holdings and portfolio value over time.
Total Stock Sold
$1.42M
$1.42M
150,000 PSTX shares
What if they kept their stock?
If Mark Gergen didn't sell their stock, today they would have:
Extra PSTX150,000 shares worth $1.43M.
This is 0.68% and $9.60K more than what they got when they sold the stock.
Insider Trading
Mark Gergen's recent stock transactions, purchases, and sales filed with the SEC.
2,546,904 shares
PSTX
Jan 8, 2025
Sale
$1.14M
PSTX at $9.46/share
Dec 10, 2024
Sale
$278.10K
PSTX at $9.27/share
Nov 26, 2024
Sale
125,000 shares
PSTX
Jan 2, 2024
Received
269,586 shares
PSTX
Mar 1, 2023
Received
357,200 shares
PSTX
Feb 1, 2022
Received
Rivals
Compare Mark Gergen with competitor CEOs and industry peers.